MeSH Browser

MeSH Heading: Rifaximin
Tree Number(s): D03.633.400.811.850; D04.345.295.750.850
Unique ID: D000078262
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000078262
Scope Note: A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of GASTROENTERITIS caused by ESCHERICHIA COLI INFECTIONS. It may also be used in the treatment of HEPATIC ENCEPHALOPATHY.
Entry Term(s): 4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin; L 105; L-105; Redactiv; Xifaxan
Pharm Action: Anti-Bacterial Agents
Gastrointestinal Agents
Registry Numbers: L36O5T016N; 0
CAS Type 1 Name: 2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, ( 2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-
Public MeSH Note: 2019; RIFAXIMIN was indexed under RIFAMYCINS 1983-2018
History Note: 2019 (1983)
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/05/21

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Rifaximin MeSH Descriptor Data 2025